CV Sciences (CVSI) Cost of Revenue (2013 - 2026)

CV Sciences has disclosed Cost of Revenue across 14 years of filings, most recently posting $1.6 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $1.6 million, down 16.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (down 73.0% YoY), and the FY2025 annual result was $2.8 million, down 11.47% from the prior year.
• Cost of Revenue came in at $1.6 million for Q1 2026 at CV Sciences, up from -$2.6 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $3.3 million in Q1 2022 to a low of -$2.6 million in Q4 2025.
• The 5-year median for Cost of Revenue is $1.9 million (2025), against an average of $1.5 million.
• Peak annual rise in Cost of Revenue reached 216.42% in 2025, while the deepest fall reached 451.08% in 2025.
• CV Sciences' Cost of Revenue stood at $2.3 million in 2022, then declined by 10.75% to $2.1 million in 2023, then tumbled by 64.06% to $740000.0 in 2024, then slumped by 451.08% to -$2.6 million in 2025, then soared by 162.86% to $1.6 million in 2026.
• The last three Cost of Revenue figures came in at $1.6 million (Q1 2026), -$2.6 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.